Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 8/12/2019
SIETES contiene 92850 citas

 
 
 1 a 20 de 101 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Jones G. GW Pharma's cannabis-based medicine to be tested in dementia. PMLiVE 2019:1. [Ref.ID 103025]
3.Enlace a cita original Cita con resumen
Klein LR, Driver BE, Miner JR, Martel ML, Hessel M, Collins JD, Horton GB, Fagerstrom E, Satpathy R, Cole JB. Intramuscular midazolam, olanzapine, ziprasidone, or haloperidol for treating acute agitation in the emergency department. Ann Emerg Med 2018:6 de junio. [Ref.ID 102665]
4.Enlace a cita original Cita con resumen
Park Y, Bateman BT, Kim DH, Hernandez-Diaz S, Patorno E, Glynn RJ, Mogun H, Hyubrechts KF. Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study. BMJ 2018;360:28 de marzo. [Ref.ID 102642]
5. Cita con resumen
Ford BM, Tai S, Fantegrossi WE, Prather PL. Synthetic pot: not your grandfathers marijuana. Trends Pharmacol Sci 2017;38:257-76. [Ref.ID 101989]
6.Enlace a cita original Cita con resumen
Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, Lopez OL, Mahoney J, Pasic J, Tan ZS, Wills CD, Rhoads R, Yager J. The American Psychiatric Association Practice Guideline on the Use of Antipsychotics to Treat Agitation or Psychosis in Patients With Dementia. Am J Psychiatry 2016;173:543-6. [Ref.ID 100329]
7.Enlace a cita original Cita con resumen
Pasina L, Zanotta D, Puricelli S, Bonoldi G. Acute neurological symptoms secondary to hypomagnesemia induced by proton pump inhibitors: a case series. Eur J Clin Pharmacol 2016;72:641-3. [Ref.ID 100252]
8.Tiene citas relacionadas Cita con resumen
Cummings JL, Lyketsos CG, Peskind ER, Porsteinsson AP, Mintzer JE, Scharre DW, De La Gandara JE, Agronin M, Davis CS, Nguyen U, Shin P, Tariot PNS, Siffert J. Effect of dextromethorphan-quinidine on agitation in patients with Alzheimer disease dementia: a randomized clinical trial. JAMA 2015;314:1242-54. [Ref.ID 99598]
9.Tiene citas relacionadas Cita con resumen
Ballard C, Sharp S, Corbett A. Dextromethorphan and quinidine for treating agitation in patients with Alzheimer disease dementia. JAMA 2015;314:1233-5. [Ref.ID 99597]
10. Cita con resumen
Trecki J, Gerona RR, Schwartz MD. Synthetic cannabinoid - Related illnesses and deahts. N Engl J Med 2015;373:103-7. [Ref.ID 99338]
11. Cita con resumen
Law R, Schier J, Martin C, Chang A, Wolkin A. Notes from the field: Increase in reported adverse health effects related to synthetic cannabinoid use — United States, January–May 2015. MMWR Morb Mortal Wkly Rep 2015;64:618-9. [Ref.ID 99193]
12. Cita con resumen
Rubin R. Call to cut antipsychotic prescriptions for older patients. JAMA 2015;313:1409. [Ref.ID 99036]
13.Enlace a cita original Cita con resumen
Anónimo. Risperidone: not to be used in vascular or mixed-type dementia. Canada . WHO Drug Information 2015;29:14. [Ref.ID 98952]
14. Cita con resumen
Anónimo. Loxapine à inhaler. Un gadget plus dangereux qu'utile!. Prescrire 2014;34:894-5. [Ref.ID 98470]
15. Cita con resumen
Anónimo. Gabapentine et prégabaline: une toxicité hépatique et sanguine parfois grave. Prescrire 2014;34:515-6. [Ref.ID 98076]
16. Cita con resumen
Read J, Cartwright C, Gibson K. Adverse emotional and interpersonal effects reported by 1829 New Zealanders while taking antidepressants. Psychiatry Research 2014;216:67-73. [Ref.ID 97503]
17. Cita con resumen
Buckley NA, Dawson AH, Isbister GK. Serotonin syndrome. BMJ 2014;348:g1626. [Ref.ID 97343]
18.Tiene citas relacionadas Cita con resumen
Porsteinsson AP, Drye LT, Pollock BG, Devanand DP, Frangakis C, Ismail Z, Marano Ch, Meinert CL, Mintzer JE, Munro CA, Pelton G, Rabins PV, Rosenberg PB, Schneider LS, Shade DM, Weintraub D, Yesavage J, Lyketsos CG, for the CitAD Research Group. Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial . JAMA 2014;311:682-91. [Ref.ID 97140]
19.Tiene citas relacionadas Cita con resumen
Small GW. Treating dementia and agitation. JAMA 2014;311:677-8. [Ref.ID 97139]
20. Cita con resumen
Reade MC, Finfer S. Sedation and delirium in the intensive care unit. N Engl J Med 2014;370:444-54. [Ref.ID 97065]
Seleccionar todas
 
 1 a 20 de 101 siguiente >>